Annual Total Expenses
$131.99 M
+$36.91 M+38.81%
30 April 2024
Summary:
KalVista Pharmaceuticals annual total expenses is currently $131.99 million, with the most recent change of +$36.91 million (+38.81%) on 30 April 2024. During the last 3 years, it has risen by +$74.07 million (+127.88%). KALV annual total expenses is now at all-time high.KALV Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$44.22 M
+$4.21 M+10.53%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly total expenses is currently $44.22 million, with the most recent change of +$4.21 million (+10.53%) on 31 July 2024. Over the past year, it has increased by +$14.47 million (+48.64%). KALV quarterly total expenses is now at all-time high.KALV Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.8% | +48.6% |
| 3 y3 years | +127.9% | +87.3% |
| 5 y5 years | +187.3% | +234.7% |
KALV Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +127.9% | at high | +284.2% |
| 5 y | 5 years | at high | +187.3% | at high | +284.2% |
| alltime | all time | at high | +3815.5% | at high | +2879.4% |
KalVista Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $44.22 M(+10.5%) |
| Apr 2024 | $131.99 M(+38.8%) | $40.00 M(+20.7%) |
| Jan 2024 | - | $33.15 M(+11.4%) |
| Oct 2023 | - | $29.75 M(+2.2%) |
| July 2023 | - | $29.09 M(+82.5%) |
| Apr 2023 | $95.09 M(+16.9%) | $15.94 M(-40.8%) |
| Jan 2023 | - | $26.95 M(+4.1%) |
| Oct 2022 | - | $25.88 M(-1.6%) |
| July 2022 | - | $26.32 M(+128.7%) |
| Apr 2022 | - | $11.51 M(-56.9%) |
| Apr 2022 | $81.31 M(+40.4%) | - |
| Jan 2022 | - | $26.68 M(+13.0%) |
| Oct 2021 | - | $23.60 M(+20.9%) |
| July 2021 | - | $19.52 M(+8.2%) |
| Apr 2021 | $57.92 M(+8.8%) | $18.04 M(+42.5%) |
| Jan 2021 | - | $12.66 M(-1.0%) |
| Oct 2020 | - | $12.78 M(-11.5%) |
| July 2020 | - | $14.44 M(+13.0%) |
| Apr 2020 | $53.22 M(+15.8%) | $12.78 M(-10.6%) |
| Jan 2020 | - | $14.30 M(+8.3%) |
| Oct 2019 | - | $13.21 M(+2.1%) |
| July 2019 | - | $12.93 M(-8.8%) |
| Apr 2019 | $45.95 M | $14.19 M(+34.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2019 | - | $10.55 M(+0.6%) |
| Oct 2018 | - | $10.48 M(-2.3%) |
| July 2018 | - | $10.73 M(+37.4%) |
| Apr 2018 | $27.10 M(+13.7%) | $7.81 M(+17.0%) |
| Jan 2018 | - | $6.68 M(-5.5%) |
| Oct 2017 | - | $7.06 M(+27.3%) |
| July 2017 | - | $5.55 M(+6.7%) |
| Apr 2017 | $23.84 M(+37.7%) | $5.20 M(-37.8%) |
| Jan 2017 | - | $8.37 M(+246.8%) |
| Sept 2016 | - | $2.41 M(-32.1%) |
| June 2016 | - | $3.55 M(-30.0%) |
| Apr 2016 | $17.31 M(-17.8%) | - |
| Mar 2016 | - | $5.08 M(-9.0%) |
| Dec 2015 | $21.07 M(+112.9%) | $5.58 M(+13.7%) |
| Sept 2015 | - | $4.91 M(-13.5%) |
| June 2015 | - | $5.67 M(+15.6%) |
| Apr 2015 | $9.89 M(-15.5%) | - |
| Mar 2015 | - | $4.91 M(+28.3%) |
| Dec 2014 | $11.71 M(+107.9%) | $3.83 M(+6.9%) |
| Sept 2014 | - | $3.58 M(+46.6%) |
| June 2014 | - | $2.44 M(+31.1%) |
| Mar 2014 | - | $1.86 M(+25.5%) |
| Dec 2013 | $5.63 M(+67.0%) | $1.48 M |
| Dec 2012 | $3.37 M | - |
FAQ
- What is KalVista Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual total expenses year-on-year change?
- What is KalVista Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly total expenses year-on-year change?
What is KalVista Pharmaceuticals annual total expenses?
The current annual total expenses of KALV is $131.99 M
What is the all time high annual total expenses for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual total expenses is $131.99 M
What is KalVista Pharmaceuticals annual total expenses year-on-year change?
Over the past year, KALV annual total expenses has changed by +$36.91 M (+38.81%)
What is KalVista Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of KALV is $44.22 M
What is the all time high quarterly total expenses for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly total expenses is $44.22 M
What is KalVista Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, KALV quarterly total expenses has changed by +$14.47 M (+48.64%)